Video Journal of Biomedicine is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
 
logo
logo
  • About Us
  • Editorial Board
  • Author Guidelines
  • FAQs
  • Videos
    • Animated Videos
    • Expert Perspective
    • Publication Perspective
    • Research Update
  • Disciplines
    • Cardiopulmonary & Vascular
    • Cell & Gene Therapy
    • Dermatology
    • Diabetes & Endocrinology
    • Gastroenterology & Hepatology
    • Genetics & Genomics
    • Global Health
    • Health & Science Communications
    • Health Economics & Outcomes Research
    • Immunology & Immunotherapy
    • Infectious Diseases & Vaccines
    • Medical Devices & Pharmaceuticals
    • Methods & Technologies
    • Nanomedicine & Nanotechnology
    • Neurology & Psychiatry
    • Obstetrics & Gynecology
    • Oncology & Hematology
    • Ophthalmology
    • Publication Practices & Ethics
    • Rheumatology & Orthopedics
    • Surgery
  • Contact

Immunology & Immunotherapy

Spesolimab Treatment for the Prevention of Flares in People with Generalized Pustular Psoriasis (GPP): A Video Summary of the EFFISAYIL® 2 Study
20 Feb 2025 Rare Diseases
Spesolimab Treatment for the Prevention of Flares in People with Generalized Pustular Psoriasis (GPP): A Video Summary of the EFFISAYIL® 2 Study
Spesolimab mechanism of action in the treatment of generalized pustular psoriasis
5 Nov 2024 Dermatology
Spesolimab mechanism of action in the treatment of generalized pustular psoriasis
Can new treatment garadacimab prevent attacks in patients with hereditary angioedema?
30 Oct 2024 Cardiopulmonary & Vascular
Can new treatment garadacimab prevent attacks in patients with hereditary angioedema?
A Video Summary of the Evolution of the RebiSmart® Electromechanical Autoinjector to Improve Usability in Support of Adherence to Subcutaneous Interferon Beta-1a Therapy for People Living with Multiple Sclerosis
28 Jun 2024 Immunology & Immunotherapy
A Video Summary of the Evolution of the RebiSmart® Electromechanical Autoinjector to Improve Usability in Support of Adherence to Subcutaneous Interferon Beta-1a Therapy for People Living with Multiple Sclerosis
Tezepelumab for severe asthma: PATHWAY and NAVIGATOR studies
30 May 2024 Immunology & Immunotherapy
Tezepelumab for severe asthma: PATHWAY and NAVIGATOR studies
VOLTAIRE-RA and VOLTAIRE-RA extension: Clinical equivalence studies of BI 695501 (Cyltezo®; adalimumab-adbm) and adalimumab reference product in rheumatoid arthritis
12 Sep 2023 Immunology & Immunotherapy
VOLTAIRE-RA and VOLTAIRE-RA extension: Clinical equivalence studies of BI 695501 (Cyltezo®; adalimumab-adbm) and adalimumab reference product in rheumatoid arthritis
Hedgehog inhibitors for basal cell carcinoma: real-world treatment patterns
19 Jul 2023 Oncology & Hematology
Hedgehog inhibitors for basal cell carcinoma: real-world treatment patterns
VOLTAIRE-CD: A phase III study of BI 695501 versus adalimumab reference product in patients with Crohn’s disease
13 Jun 2023 Immunology & Immunotherapy
VOLTAIRE-CD: A phase III study of BI 695501 versus adalimumab reference product in patients with Crohn’s disease
When should a PCP refer a patient with pustular psoriasis to a dermatologist?
16 Aug 2021 Dermatology
When should a PCP refer a patient with pustular psoriasis to a dermatologist?
Links
  • Home
  • About Us
  • Editorial Board
  • Author Guidelines
  • FAQs
  • Videos
Office info

Video Journal of Biomedicine is powered by Taylor & Francis Group

Video Journal of Biomedicine, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
Contact Us
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2025 Video Journal of Biomedicine
We use cookies to improve your experience on our site and to show you relevant information and advertising. By continuing to use our website, you are agreeing to the policy and privacy policy. For more information about the cookies we collect from you and information about our policies, visit our cookie policy and privacy policy.